Generation Bio Total Liabilities 2020-2023 | GBIO

Generation Bio total liabilities from 2020 to 2023. Total liabilities can be defined as the total value of all possible claims against the corporation.
Generation Bio Annual Total Liabilities
(Millions of US $)
2023 $172
2022 $94
2021 $95
2020 $26
2019 $25
Generation Bio Quarterly Total Liabilities
(Millions of US $)
2023-12-31 $172
2023-09-30 $150
2023-06-30 $151
2023-03-31 $152
2022-12-31 $94
2022-09-30 $94
2022-06-30 $94
2022-03-31 $91
2021-12-31 $95
2021-09-30 $57
2021-06-30 $57
2021-03-31 $55
2020-12-31 $26
2020-09-30 $24
2020-06-30 $27
2020-03-31 $0
2019-12-31
2019-09-30 $0
2019-06-30 $0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.211B $0.006B
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.673B 5.66
Dr Reddy's Laboratories (RDY) India $12.551B 19.84
Aspen Pharmacare (APNHY) South Africa $5.574B 0.00
BridgeBio Pharma (BBIO) United States $5.208B 0.00
Bausch Health Cos (BHC) Canada $2.868B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.042B 14.20
Supernus Pharmaceuticals (SUPN) United States $1.695B 0.00
Taysha Gene Therapies (TSHA) United States $0.481B 0.00
Personalis (PSNL) United States $0.078B 0.00
Assembly Biosciences (ASMB) United States $0.072B 0.00
Acasti Pharma (ACST) Canada $0.028B 0.00
Sol-Gel Technologies (SLGL) Israel $0.024B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00